TAG:
lab manager
More Crime, More Consolidation, and a New Threat
By R. Lewis Dark | From the Volume XII No. 6 – April 18, 2005 Issue
IT’S A SHAME THAT OUR LEAD STORY IN THIS ISSUE IS CRIMINAL INDICTMENTS of six former IMPATH executives. It is a black mark on the lab industry and is just one more factor that makes it tougher for honest laboratorians to successfully lobby Congress on adequate funding for laborator…
Privacy Officer Shares Lessons on ID Theft
By Robert Michel | From the Volume XII No. 5 – March 28, 2005 Issue
CEO SUMMARY: “Nothing teaches like experience.” That adage aptly describes the lessons learned at a Seattle hospital after a case of patient identity theft surfaced. Laboratories and pathology groups must be just as alert to the potential for patient identity theft as they are to inap…
“March 28, 2005 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XII No. 5 – March 28, 2005 Issue
For lab managers and pathologists tracking the growth of e-commerce, here’s a revealing statistic. The Federal Reserve Bank released numbers showing that 2003 was the first year where the number of electronic payment transactions exceeded the number of trans- actions paid by check….
FL Medicaid Gives Up On Statewide Lab Contract
By Robert Michel | From the Volume XII No. 4 – March 7, 2005 Issue
CEO SUMMARY: With the withdrawal of the December 13, 2004 “Invitation to Negotiate” (ITN), Florida’s Medicaid bureaucrats seem to have thrown in the towel—at least for the moment—on the effort to give a single laboratory company an exclusive three-year contract to provide labora…
Bi-Annual Look at Trends Reshaping Clinical Labs
By Robert Michel | From the Volume XII No. 2 – January 24, 2005 Issue
CEO SUMMARY: Among other things, we declare the end to the heyday of the independent commercial lab company which offers a broad test menu to all types of office-based physicians. In its place springs forth the specialty or niche testing laboratory. Small and focused on a specific number …
Roche/Affymetrix Microarray Cleared for Clinical Use by FDA
By Robert Michel | From the Volume XII No. 1 – January 3, 2005 Issue
MOLECULAR DIAGNOSTICS took a big step forward in December. During the month, the Food and Drug Administration (FDA) cleared the first microarray instrument system and microarray-based laboratory test for clinical use. The FDA announced on December 23, 2004 that it had cleared the Ge…
Florida Medicaid Contract Is On-Again, Off-Again
By Robert Michel | From the Volume XII No. 1 – January 3, 2005 Issue
CEO SUMMARY: Start with a flawed idea: Medicaid lab testing costs in Florida can be cut by awarding an exclusive statewide contract to one laboratory company. Compound that bad idea by designing a contract awards process that guarantees the state will pay twice for a number of tests while…
British Early-Adopter Labs Respond to New Trends
By Robert Michel | From the Volume XI No. 17 – December 13, 2004 Issue
CEO SUMMARY: On which side of the Atlantic are clinical labs better operated? This February will be the third consecutive year that progressive lab leaders from the USA and the United Kingdom convene in England to explore each country’s laboratory best practices, to swap innovations, an…
Less Complex IT Technologies Will Propel Use of The Internet
By Robert Michel | From the Volume XI No. 17 – December 13, 2004 Issue
EXPERTS in information technologies (IT) predict that the next paradigm shift in IT will come from reducing the complexity of software and hardware. Analyst Steven Milunovic of Merrill Lynchstates that, as complex IT systems are simplified for users, every single employee will be ex…
“December 13, 2004 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XI No. 17 – December 13, 2004 Issue
THE DARK REPORT once again was first with timely intelligence. This time we scooped Business Week and other national business sources with our analysis of the impending arrival of HPV vaccines—presented in our November 22, 2004 issue. Business Week published their HPV vaccine stor…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized